Table 3.
Analysis of clinical factors in the National Surgical Quality Improvement Program database associated with major morbidity following hepatectomy
| Strata | Risk factor | MV P-value | Odds ratio |
|---|---|---|---|
| Preoperative | ASA score | 0.001 | 1.4 |
| Smoking | 0.0001 | 1.7 | |
| Biochemistries | Elevated alkaline phosphatase | 0.0001 | 4.9 |
| Low albumin | 0.006 | 2.8 | |
| Elevated partial thromboplastin time | 0.047 | 2.0 | |
| Perioperative | Extent of hepatectomy | 0.0001 | 1.8 |
| Intraoperative red cell transfusion | 0.0001 | 2.2 | |
| Prolonged operative time | 0.011 | 1.6 | |
| Postoperative red cell transfusion | 0.001 | 1.4 |
MV, multivariate; ASA, American Society of Anesthesiologists